News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Sangamo Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
Down Syndrome’s Extra Chromosome Silenced, University of Massachusetts Medical School, Sangamo BioSciences, Inc. Study
July 18, 2013
·
5 min read
Drug Development
Double Whammy Gene Therapy Clears HIV From Body, Sangamo BioSciences, Inc. Reveals
September 23, 2011
·
1 min read
Drug Development
New AIDS Approach Disrupts Patient’s DNA, Sangamo BioSciences, Inc. Announces
February 3, 2009
·
1 min read
Biotech Beach
The Week In Review: Biotech Treks Higher
February 5, 2007
·
1 min read
Biotech Beach
The Day In Review: Deals Dominate Biotech News
December 12, 2006
·
1 min read
The Day In Review: News On Multiple Sclerosis Drugs
September 28, 2006
·
1 min read
Biotech Beach
The Day In Review: Diabetes News Rules
June 13, 2006
·
1 min read
Biotech Beach
The Day In Review: Pfizer Inc. Buys Another Biotech
April 7, 2006
·
1 min read
Biotech Beach
Sangamo BioSciences, Inc. Reports Success Using ZNPs To Fight Aids
December 19, 2005
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation
March 29, 2022
·
6 min read
Biotech Bay
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences - Feb 28, 2022
February 28, 2022
·
1 min read
Business
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
February 24, 2022
·
16 min read
Business
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2021 Conference Call and Webcast
February 17, 2022
·
1 min read
Drug Development
Sangamo Therapeutics Announces Updated Preliminary Phase 1/2 Data Showing Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Patients With Fabry Disease
February 7, 2022
·
8 min read
Business
Sangamo Announces Transition of SAR445136 Sickle Cell Disease Program From Sanofi to Sangamo
January 6, 2022
·
7 min read
Biotech Bay
Sangamo Therapeutics Announces Participation at H.C. Wainwright BIOCONNECT Virtual Conference
January 4, 2022
·
1 min read
Drug Development
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy
December 12, 2021
·
13 min read
Drug Development
Sangamo Therapeutics Announces Updated Preliminary SAR445136 Phase 1/2 Proof-of-Concept Data Showing Tolerability and Sustained Effects in Sickle Cell Disease
December 12, 2021
·
6 min read
Biotech Bay
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences - Nov 09, 2021
November 9, 2021
·
1 min read
